Floatz logo

m28z1xxpd1dnr car

Mesothelin Positive

Memorial Sloan Kettering Cancer CenterCell therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Mesothelin Positive cohort.

Asset / SponsorPhaseRating
Anetumab Ravtansine
Mayo Clinic
Phase 1CC
Atezolizumab
Mayo Clinic
Phase 1CC

Same molecule, other indications

m28z1xxpd1dnr car is also rated in:

neoplasmDormant
CC
Indicative ·
43 / 100
View asset →
gastroesophageal adenocarcinomaDormant
CC
Indicative ·
43 / 100
View asset →
diabetes mellitusDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →